Hikal

Hikal, an Indian pharmaceutical preparation manufacturer, is committed to reducing its environmental impact. For the reporting year 2024, Hikal reported Scope 1 emissions of approximately 21,410,710 kg CO2e and Scope 2 emissions of approximately 67,287,010 kg CO2e. The previous year, 2023, saw Scope 1 emissions at approximately 26,793,240 kg CO2e and Scope 2 emissions at approximately 67,737,300 kg CO2e. In 2022, Scope 1 emissions were reported at approximately 57,457,000 kg CO2e, with Scope 2 data not being specified for that year.

Hikal has set ambitious decarbonisation targets, aiming for a 30% reduction in Scope 1 and 2 emissions by 2027-28, compared to 2022-23 baseline levels. While Hikal is committed to near-term targets, its latest available data indicates it is not yet on track to meet its two-year reduction goals. The company has not yet disclosed Scope 3 emissions data, with purchased goods and services being a notable missing data point.